Work

Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitors.

Year: 1989

Type: article

Source: PubMed

Authors: M Da Prada, R Kettler, H H Keller, W P Burkard, W E Haefely

Institution: F. Hoffmann-La Roche AG

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology (medical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2414081879

FWCI: 2.365

Cites:

Cited by: 33

Related to: 10